BRN Discussion Ongoing

[Sirod69]

Such a good morning, I love seeing green and especially dark green. And I love reading here, so every morning can start.
We are currently 19% PLUS

GROUP CUDDLING!!

 

[Jasonk]

I was just thinking the exact same thing Genie!

Actually just did a quick Google search a few minutes ago..

An article, would be as telling, as a speeding ticket..

I've been buying off the back of no MF articles.. could be my new ASX strategy . Starting to ponder if they are paid to write by 3rd parties.

 

[DingoBorat]

I've been buying off the back of no MF articles.. could be my new ASX strategy . Starting to ponder if they are paid to write by 3rd parties.

Starting?

 

[IloveLamp]

The Motley Fool (James Mickleboro) would look more foolish with the way
he has been throwing shit at BrainChip and telling everybody and anybody
how not to touch it with a 10 foot pole, and now turn around and tell everybody
and anybody that it is a BUY.
I don't think so, at the moment it looks like the shit he has been throwing has
rebounded right back in his face.

Clearly you haven't been following their other articles. It's classic mf behaviour. They've done it time and time again to other stocks

No morals. Imo they care not about their lack of credibility. Just the short term $

Opinion only

 

[Jasonk]

Starting?

I first thought it was just f@%kery for the shit they are trying to sell and not so much collusion with a 3rd party.. best not speak to loudly might end up with a letter from them

 

[CHIPS]

It’s time to ban penny stocks from Australia’s flagship share index

The collapse of Lake Resources and poor performance of BrainChip and Imugene shows why there’s no place for penny stocks in a serious sharemarket index.

www.afr.com

I want to see this Tom Richardson cry ... the latest 2025, preferably now!
________________________________________________________________________________________________________________________

It’s time to ban penny stocks from Australia’s flagship share index​

If you want to attract and win the trust of serious overseas investors including sovereign wealth funds, pension funds, and asset managers you don’t want a flagship index pockmarked by penny stocks.

Tom Richardson Journalist
Jun 26, 2023 – 11.00am

Penny stocks are rearing their ugly heads on Australia’s flagship S&P/ASX 200 Index with alarming regularity, in a reflection of the market’s deteriorating quality, as the ASX shrinks for the first time in 18 years.
Last week, Australia’s flagship index resembled a penny stock casino, with shares in lithium explorer Lake Resources crashing 38 per cent to 29.5¢ after it revealed a six-year delay to its Argentinian lithium project. Speculative biotech Imugene finished the week at just 8.9¢, with tech hopeful BrainChip losing 13.8 per cent over the week to 34.5¢.

The benchmark S&P/ASX 200 index now has multiple stocks trading below $1 as the market shrinks for the first time in 18 years. iStock
The performance across what is supposed to be an index of blue-chip businesses is a growing problem, given passive index tracking funds mean almost every Australian has some financial interest in the success of the S&P/ASX 200.
Moreover, BrainChip, Imugene, and Lake Resources share common traits of unproven business models, virtually no revenue, heavy share selling by insiders, and penny stock prices that equal daily volatility.
All this hasn’t excluded them from benchmark membership, although other jurisdictions would have no truck with this nonsense.

RELATED QUOTES​

ASXASX Limited​

$67.160 -0.06%
1 year1 day


Updated: Feb 12, 2024 – 8.22pm. Data is 20 mins delayed.
View ASX related articles

IMUImugene Limited​

$0.110 4.76%

BRNBrainchip Holdings​

$0.260 15.56%

LKELake Resources​

$0.091 -3.19%

Poor returns​

In the US, penny stocks – defined as those that trade below $US1 – are banned for good reason. They’re viewed as ripe for manipulation. A 10¢ stock only needs 10 bids higher to 20¢ to soar 100 per cent and double a manipulator’s money.
By comparison 10 bids higher on a $20 stock to $20.10 will only add 0.5 per cent, which shows why penny stocks are attractive to those seeking to get rich quick, illicitly.

In the age of anonymous social media and online chatrooms, it’s easy for an organised group to create false hype around a business and use multiple trading accounts to sell the stock to themselves at incrementally higher prices in a bid to inflate valuations.
The hundreds of millions of dollars of easy profits on offer mean penny stocks are regularly targeted by promoters. The US regulator, the SEC, charged 16 defendants last year after it said it uncovered a multi-year fraudulent penny stock scheme that generated more than $US194 million ($290 million) in illegal profits.

Last September, The Australian Financial Review revealed Telegram pump-and-dump groups actively targeted penny stocks like Australasian Gold, which had a low number of shares on issue, relatively large amount held by top-20 shareholders, and a price-sensitive announcement in the market to evade trading halts from suspicious regulators.

There’s no suggestion Imugene has been targeted by manipulators, but it currently has a massive 6.42 billion shares on issue to equal a $571 million market cap at 8.9¢. In other words, it could add or lose a $1 billion in value with just a 16¢-share price move.
The cancer research group has no potential treatments in the Phase III clinical trial phase, but joined Standard & Poor’s’ index of Australia’s top 200 companies in December 2021 and has cratered more than 80 per cent since.
Lake Resources entered the S&P/ASX 200 Index in June 2022 and its shares have also plunged more than 80 per cent since.

As a corollary, if you want to attract and win the trust of serious overseas investors – including sovereign wealth funds, pension funds, and asset managers – you don’t want a flagship index pockmarked by penny stocks.
The UK’s regulatory environment forces around 850 smaller, speculative companies to list on its Alternative Investment Market to ringfence the integrity and attractiveness of its benchmark FTSE 100 Index. It makes sense to separate out speculative businesses from real businesses to protect investors, while still helping small companies attract capital.

Elsewhere, Australia’s rival for Asia-Pacific capital markets, Singapore, built its economy on tough financial services regulation that gave international investors confidence in its markets and a competitive advantage over dozens of regional competitors. The island state teems with international law firms, hedge funds, and asset managers precisely because sound regulation attracts capital and brings jobs.

Today, a business can list on the ASX with a minimum market cap of just $15 million, with inclusion in the S&P/ASX 200 based on minimum free floats, market cap, and trading volumes.
As a starting point, the S&P/ASX 200 should exclude businesses that have zero revenue and stock prices under $1 to protect index buyers and other market participants.

 

[wilzy123]

Brainchip is a team, Peter is the genius, but going forward you need a team all on board to take this company to the nxt level, Our previous CEO Did a job but his time was up, Sean is the right man for the job

Hey deadbeat. You still got a pulse?

 

[Tothemoon24]

Software: One of the key ingredients of the coming transformation of the automotive industry. | Valeo

Software: One of the key ingredients of the coming transformation of the automotive industry. 👨‍💻 And Valeo is going to be there to make the ride as smooth as possible... literally! Watch this video to better understand just a little of how we plan to do so. 👀

www.linkedin.com

 

[Diogenese]

It’s time to ban penny stocks from Australia’s flagship share index

The collapse of Lake Resources and poor performance of BrainChip and Imugene shows why there’s no place for penny stocks in a serious sharemarket index.

www.afr.com

I want to see this Tom Richardson cry ... the latest 2025, preferably now!
________________________________________________________________________________________________________________________

It’s time to ban penny stocks from Australia’s flagship share index​

If you want to attract and win the trust of serious overseas investors including sovereign wealth funds, pension funds, and asset managers you don’t want a flagship index pockmarked by penny stocks.

Tom Richardson Journalist
Jun 26, 2023 – 11.00am

Penny stocks are rearing their ugly heads on Australia’s flagship S&P/ASX 200 Index with alarming regularity, in a reflection of the market’s deteriorating quality, as the ASX shrinks for the first time in 18 years.
Last week, Australia’s flagship index resembled a penny stock casino, with shares in lithium explorer Lake Resources crashing 38 per cent to 29.5¢ after it revealed a six-year delay to its Argentinian lithium project. Speculative biotech Imugene finished the week at just 8.9¢, with tech hopeful BrainChip losing 13.8 per cent over the week to 34.5¢.

The benchmark S&P/ASX 200 index now has multiple stocks trading below $1 as the market shrinks for the first time in 18 years. iStock
The performance across what is supposed to be an index of blue-chip businesses is a growing problem, given passive index tracking funds mean almost every Australian has some financial interest in the success of the S&P/ASX 200.
Moreover, BrainChip, Imugene, and Lake Resources share common traits of unproven business models, virtually no revenue, heavy share selling by insiders, and penny stock prices that equal daily volatility.
All this hasn’t excluded them from benchmark membership, although other jurisdictions would have no truck with this nonsense.

RELATED QUOTES​

ASXASX Limited​

$67.160 -0.06%
1 year1 day


Updated: Feb 12, 2024 – 8.22pm. Data is 20 mins delayed.
View ASX related articles

IMUImugene Limited​

$0.110 4.76%

BRNBrainchip Holdings​

$0.260 15.56%

LKELake Resources​

$0.091 -3.19%

Poor returns​

In the US, penny stocks – defined as those that trade below $US1 – are banned for good reason. They’re viewed as ripe for manipulation. A 10¢ stock only needs 10 bids higher to 20¢ to soar 100 per cent and double a manipulator’s money.
By comparison 10 bids higher on a $20 stock to $20.10 will only add 0.5 per cent, which shows why penny stocks are attractive to those seeking to get rich quick, illicitly.

In the age of anonymous social media and online chatrooms, it’s easy for an organised group to create false hype around a business and use multiple trading accounts to sell the stock to themselves at incrementally higher prices in a bid to inflate valuations.
The hundreds of millions of dollars of easy profits on offer mean penny stocks are regularly targeted by promoters. The US regulator, the SEC, charged 16 defendants last year after it said it uncovered a multi-year fraudulent penny stock scheme that generated more than $US194 million ($290 million) in illegal profits.

Last September, The Australian Financial Review revealed Telegram pump-and-dump groups actively targeted penny stocks like Australasian Gold, which had a low number of shares on issue, relatively large amount held by top-20 shareholders, and a price-sensitive announcement in the market to evade trading halts from suspicious regulators.

There’s no suggestion Imugene has been targeted by manipulators, but it currently has a massive 6.42 billion shares on issue to equal a $571 million market cap at 8.9¢. In other words, it could add or lose a $1 billion in value with just a 16¢-share price move.
The cancer research group has no potential treatments in the Phase III clinical trial phase, but joined Standard & Poor’s’ index of Australia’s top 200 companies in December 2021 and has cratered more than 80 per cent since.
Lake Resources entered the S&P/ASX 200 Index in June 2022 and its shares have also plunged more than 80 per cent since.

As a corollary, if you want to attract and win the trust of serious overseas investors – including sovereign wealth funds, pension funds, and asset managers – you don’t want a flagship index pockmarked by penny stocks.
The UK’s regulatory environment forces around 850 smaller, speculative companies to list on its Alternative Investment Market to ringfence the integrity and attractiveness of its benchmark FTSE 100 Index. It makes sense to separate out speculative businesses from real businesses to protect investors, while still helping small companies attract capital.

Elsewhere, Australia’s rival for Asia-Pacific capital markets, Singapore, built its economy on tough financial services regulation that gave international investors confidence in its markets and a competitive advantage over dozens of regional competitors. The island state teems with international law firms, hedge funds, and asset managers precisely because sound regulation attracts capital and brings jobs.

Today, a business can list on the ASX with a minimum market cap of just $15 million, with inclusion in the S&P/ASX 200 based on minimum free floats, market cap, and trading volumes.
As a starting point, the S&P/ASX 200 should exclude businesses that have zero revenue and stock prices under $1 to protect index buyers and other market participants.

... or maybe ASIC, like the SEC, should take on the manipulators, and take ASX to task for facilitating manipulation ... and ban shorting, the tool of the manipulators.

It's still illegal to carry housebreaking tools, so why do we allow shorting?

https://www.armstronglegal.com.au/criminal-law/nsw/offences/possess-housebreaking-implements/

 

[cosors]

View attachment 56609

Wonderful! 11 is the lucky number of my city Cologne and here the fools are out of control The Rose Monday parade is just starting. It's going to be a marvellous day!

 

[DingoBorat]

It’s time to ban penny stocks from Australia’s flagship share index

The collapse of Lake Resources and poor performance of BrainChip and Imugene shows why there’s no place for penny stocks in a serious sharemarket index.

www.afr.com

I want to see this Tom Richardson cry ... the latest 2025, preferably now!
________________________________________________________________________________________________________________________

It’s time to ban penny stocks from Australia’s flagship share index​

If you want to attract and win the trust of serious overseas investors including sovereign wealth funds, pension funds, and asset managers you don’t want a flagship index pockmarked by penny stocks.

Tom Richardson Journalist
Jun 26, 2023 – 11.00am

Penny stocks are rearing their ugly heads on Australia’s flagship S&P/ASX 200 Index with alarming regularity, in a reflection of the market’s deteriorating quality, as the ASX shrinks for the first time in 18 years.
Last week, Australia’s flagship index resembled a penny stock casino, with shares in lithium explorer Lake Resources crashing 38 per cent to 29.5¢ after it revealed a six-year delay to its Argentinian lithium project. Speculative biotech Imugene finished the week at just 8.9¢, with tech hopeful BrainChip losing 13.8 per cent over the week to 34.5¢.

The benchmark S&P/ASX 200 index now has multiple stocks trading below $1 as the market shrinks for the first time in 18 years. iStock
The performance across what is supposed to be an index of blue-chip businesses is a growing problem, given passive index tracking funds mean almost every Australian has some financial interest in the success of the S&P/ASX 200.
Moreover, BrainChip, Imugene, and Lake Resources share common traits of unproven business models, virtually no revenue, heavy share selling by insiders, and penny stock prices that equal daily volatility.
All this hasn’t excluded them from benchmark membership, although other jurisdictions would have no truck with this nonsense.

RELATED QUOTES​

ASXASX Limited​

$67.160 -0.06%
1 year1 day


Updated: Feb 12, 2024 – 8.22pm. Data is 20 mins delayed.
View ASX related articles

IMUImugene Limited​

$0.110 4.76%

BRNBrainchip Holdings​

$0.260 15.56%

LKELake Resources​

$0.091 -3.19%

Poor returns​

In the US, penny stocks – defined as those that trade below $US1 – are banned for good reason. They’re viewed as ripe for manipulation. A 10¢ stock only needs 10 bids higher to 20¢ to soar 100 per cent and double a manipulator’s money.
By comparison 10 bids higher on a $20 stock to $20.10 will only add 0.5 per cent, which shows why penny stocks are attractive to those seeking to get rich quick, illicitly.

In the age of anonymous social media and online chatrooms, it’s easy for an organised group to create false hype around a business and use multiple trading accounts to sell the stock to themselves at incrementally higher prices in a bid to inflate valuations.
The hundreds of millions of dollars of easy profits on offer mean penny stocks are regularly targeted by promoters. The US regulator, the SEC, charged 16 defendants last year after it said it uncovered a multi-year fraudulent penny stock scheme that generated more than $US194 million ($290 million) in illegal profits.

Last September, The Australian Financial Review revealed Telegram pump-and-dump groups actively targeted penny stocks like Australasian Gold, which had a low number of shares on issue, relatively large amount held by top-20 shareholders, and a price-sensitive announcement in the market to evade trading halts from suspicious regulators.

There’s no suggestion Imugene has been targeted by manipulators, but it currently has a massive 6.42 billion shares on issue to equal a $571 million market cap at 8.9¢. In other words, it could add or lose a $1 billion in value with just a 16¢-share price move.
The cancer research group has no potential treatments in the Phase III clinical trial phase, but joined Standard & Poor’s’ index of Australia’s top 200 companies in December 2021 and has cratered more than 80 per cent since.
Lake Resources entered the S&P/ASX 200 Index in June 2022 and its shares have also plunged more than 80 per cent since.

As a corollary, if you want to attract and win the trust of serious overseas investors – including sovereign wealth funds, pension funds, and asset managers – you don’t want a flagship index pockmarked by penny stocks.
The UK’s regulatory environment forces around 850 smaller, speculative companies to list on its Alternative Investment Market to ringfence the integrity and attractiveness of its benchmark FTSE 100 Index. It makes sense to separate out speculative businesses from real businesses to protect investors, while still helping small companies attract capital.

Elsewhere, Australia’s rival for Asia-Pacific capital markets, Singapore, built its economy on tough financial services regulation that gave international investors confidence in its markets and a competitive advantage over dozens of regional competitors. The island state teems with international law firms, hedge funds, and asset managers precisely because sound regulation attracts capital and brings jobs.

Today, a business can list on the ASX with a minimum market cap of just $15 million, with inclusion in the S&P/ASX 200 based on minimum free floats, market cap, and trading volumes.
As a starting point, the S&P/ASX 200 should exclude businesses that have zero revenue and stock prices under $1 to protect index buyers and other market participants.

This Dick is right.

"As a starting point, the S&P/ASX 200 should exclude businesses that have zero revenue and stock prices under $1 to protect index buyers and other market participants"


We need BRN's share price over a dollar, as quickly as possible, to thrawt petty manipulators and pave our way for re-entry into the index, on solid revenue.

We just have to do something, about our "unproven" business plan..

 

[Luppo71]

Evening all,
I don't read everything on here so sorry if reposted but this has to be one of the best if not the best article I have read on explaining what Brainchip and Akida does and will do into the future.
Great read.
And another great day in the green, good luck all.

BrainChip: The Cloud-Free Future is Here

Comprehending a revolutionary concept is not easy. Too often we get intimidated by jargon or struggle to see the core concept. That happened to me when I became curious about BrainChip (NASDAQ: BRCHF, ASX: BRN).

disruptiveinvestmentideas.substack.com

 

[cosors]

It's only 11 o'clock in the morning here and trading continues until 10 in the evening. So far it looks very good! I haven't seen such a good start to the day here for a long time. The OTC figure number is not yet up to date and is from Friday.

 

[CHIPS]

Evening all,
I don't read everything on here so sorry if reposted but this has to be one of the best if not the best article I have read on explaining what Brainchip and Akida does and will do into the future.
Great read.
And another great day in the green, good luck all.

BrainChip: The Cloud-Free Future is Here

Comprehending a revolutionary concept is not easy. Too often we get intimidated by jargon or struggle to see the core concept. That happened to me when I became curious about BrainChip (NASDAQ: BRCHF, ASX: BRN).

disruptiveinvestmentideas.substack.com

The author himself posted it a few days ago but thank you anyway. Better twice than not at all. It is a great article!

 

[Fact Finder]

This Dick is right.

"As a starting point, the S&P/ASX 200 should exclude businesses that have zero revenue and stock prices under $1 to protect index buyers and other market participants"


We need BRN's share price over a dollar, as quickly as possible, to thrawt petty manipulators and pave our way for re-entry into the index, on solid revenue.

We just have to do something, about our "unproven" business plan..

Hi DB
I am sure a collective cheer went up from every venture capitalist in the world with the idea that companies have to have revenue secured before they can list.

The only reason you hold shares in Brainchip is because it didn’t have to go to venture capital to get off the ground.

I am in Diogenese’s camp the issue is not Brainchip being listed it is the failure of ASIC to regulate and the shorting of pre revenue companies being a legal activity.

Shorting should be banned fullstop but at the very least pre revenue companies should be protected.

My opinion only DYOR
Fact Finder

 

[DingoBorat]

Hi DB
I am sure a collective cheer went up from every venture capitalist in the world with the idea that companies have to have revenue secured before they can list.

The only reason you hold shares in Brainchip is because it didn’t have to go to venture capital to get off the ground.

I am in Diogenese’s camp the issue is not Brainchip being listed it is the failure of ASIC to regulate and the shorting of pre revenue companies being a legal activity.

Shorting should be banned fullstop but at the very least pre revenue companies should be protected.

My opinion only DYOR
Fact Finder

The author wasn't referring to being listed on the ASX, just entry into the ASX200..

Entering the ASX200, without regular sustainable revenue, did us no favors..

 

[CHIPS]

Wonderful! 11 is the lucky number of my city Cologne and here the fools are out of control The Rose Monday parade is just starting. It's going to be a marvellous day!

And after a lot of rain, again the sun comes out, like every year at Rose Monday.

https://www1.wdr.de/unterhaltung/karneval/rosenmontagszug-koeln-138.html (for those who want to have a look at it live)

 

[Newk R]

When you look at the all time high, the sp looks pitiful. However, when you look at the end of financial year historical prices, it puts in a bit of perspective. Add the current movements, and if you base your investment performances on those criteria, maybe things aren't that bad.

Year Closing Price Last Trade

30 June 2023 $0.365
30 June 2022 $0.800
30 June2021 $0.490
30 June2020 $0.081
30 June 2019 $0.072
28 June2018 $0.130
29 June2017 $0.160
28 June2016 $0.140

 

[DingoBorat]

Evening all,
I don't read everything on here so sorry if reposted but this has to be one of the best if not the best article I have read on explaining what Brainchip and Akida does and will do into the future.
Great read.
And another great day in the green, good luck all.

BrainChip: The Cloud-Free Future is Here

Comprehending a revolutionary concept is not easy. Too often we get intimidated by jargon or struggle to see the core concept. That happened to me when I became curious about BrainChip (NASDAQ: BRCHF, ASX: BRN).

disruptiveinvestmentideas.substack.com

Agree Luppo, a Great article to sell BrainChip's value proposition, while still outlining the risks.

Anyone who wants to give someone a better understanding, who may be interested in investing in BRN, should be made to read it.

How they accomplish that, is none of my business..

 

[DingoBorat]

And after a lot of rain, again the sun comes out, like every year at Rose Monday.

https://www1.wdr.de/unterhaltung/karneval/rosenmontagszug-koeln-138.html (for those who want to have a look at it live)

Why do Germans sound like they are swearing, when they are excited